Dr. Mark Kotter, MD, PhD | Source | Founder, CEO, Board Member at bit.bio
Dr. Mark Kotter, MD, PhD
Mark is a Stem Cell Biologist and Neurosurgeon at the University of Cambridge. Aged nineteen, he decided to pursue a career in medicine to serve others and to make a difference in people’s lives. His curiosity led him down a path of Clinical Service and Laboratory Discovery. He became fascinated by synthetic biology, as he saw it as the key to a new generation of medicines. He is the Founder of bit.bio and Co-founder of the cultured meat start-up Meatable.
-
bit.bio
Founder, CEO, Board Member
-
bit.bio’s New Huntington’s Disease Human Cell Model Set to Accelerate Drug Discovery and Screening
bit.bio, a synthetic biology company working on developing and providing every human cell type at scale, with the aim of transforming the research and
Article
-
bit.bio's mission is coding cells for novel cures. The launch of our Huntington's disease model provides the industry with an advanced cellular tool to support the study of a devastating condition with high unmet clinical needs. Our opti-ox technology allows the development of consistent and scalable biological standards that can support the evolution of a new generation of medicines. It adds depth to our broadening R&D cell type product pipeline, each product will transition to its own product line.